By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Corbus Pharmaceuticals, Inc.  

100 River Ridge Drive

Norwood  Massachusetts  02062   U.S.A.
Phone: 1-617-963-0100 Fax: 1-617-663-6085


Company News
Corbus Receives FDA Clearance To Initiate Phase 2 Clinical Study of Resunab For The Treatment Of Cystic Fibrosis 5/18/2015 12:07:37 PM
Corbus Will Interview Twice as Many Candidates in 2015 as Its Ranks Grow 5/18/2015 12:05:26 PM
Corbus Reports 2015 First Quarter Financial Results And Provides Business Update 5/14/2015 11:02:55 AM
Corbus Appoints Charles N. Serhan, Ph.D., To Scientific Advisory Board 5/14/2015 11:00:50 AM
Corbus To Present At The Cystic Fibrosis Workshop Hosted By JMP Securities On May 8, 2015 5/5/2015 11:20:25 AM
Tiny Corbus Looks to Give Vertex (VRTX) Some Competition With Experimental Cystic Fibrosis Drug 5/5/2015 6:22:32 AM
Corbus Pharmaceuticals, Inc. Receives $5 Million Development Award From Cystic Fibrosis Foundation Therapeutics To Advance Resunab Clinical Program 4/24/2015 11:38:36 AM
Corbus Pharmaceuticals, Inc. Announces Initiation Of Trading On The Nasdaq Capital Market 4/17/2015 11:49:20 AM
Corbus Pharmaceuticals, Inc. To Ring The Nasdaq Stock Market Closing Bell 4/16/2015 8:38:35 AM
Corbus Pharmaceuticals, Inc. Announces Uplisting To The NASDAQ Capital Market 4/15/2015 12:01:11 PM